We acquire, develop and market a portfolio of mature branded medicines globally. Acquire We acquire mature (i.e. post-patent expiry), established branded prescription medicines from large cap and specialty pharma. Develop We develop line extensions (new formulations or new markets) to the medicines we acquire. We also develop our own niche generic medicines in-house. Market We currently own and market a portfolio of more than 15 medicines and operate in more than 130 markets globally.
We acquire, develop and market a portfolio of mature branded medicines globally. Acquire We acquire mature (i.e. post-patent expiry), established branded prescription medicines from large cap and specialty pharma. Develop We develop line extensions (new formulations or new markets) to the medicines we acquire. We also develop our own niche generic medicines in-house. Market We currently own and market a portfolio of more than 15 medicines and operate in more than 130 markets globally.